Measles immunity and immunization status in under-5-year-old children in New South Wales: a population-based study

M J Ferson1, P W Robertson, J W Donovan

  • 1Public Health Unit, South Eastern Sydney Area Health Service, Zetland, New South Wales, Australia. mfers@doh.health.nsw.gov.au

Insights

Only 80% of young children in New South Wales are immune to measles, indicating a need for improved vaccination strategies. This study highlights the importance of accurate measles immunization records for children.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Public Health Surveillance

Background:

  • Measles outbreaks pose a significant public health risk, particularly in urban populations.
  • Assessing true measles immunity in young children is crucial for effective disease control.
  • Documented immunization history may not always reflect actual serological immunity.

Purpose of the Study:

  • To determine the measles immunity prevalence in 1-4-year-old children in New South Wales (NSW).
  • To compare documented immunization status with serologically confirmed immunity.
  • To identify gaps in measles protection within this age group.

Main Methods:

  • A population-based seroprevalence survey was conducted in NSW, Australia.
  • Immune status was assessed using two enzyme immunoassays on plasma samples.
  • Data on documented measles immunization were collected via interviews and record verification.

Main Results:

  • Of 347 children with adequate samples, 80.4% demonstrated measles immunity.
  • Parent-reported immunization status had a concordance of 63.9% with available records.
  • Serological immunity was slightly higher in children with documented records (84.4%) versus those without (76.3%), though not statistically significant (P=0.07).

Conclusions:

  • The estimated measles immunity prevalence of 80% in NSW children aged 1-4 years is insufficient to prevent outbreaks.
  • Urgent strategies are needed to increase measles immunity, such as adjusting the vaccination schedule.
  • Mass immunization campaigns targeting preschool-aged children are recommended to bolster population immunity.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...